首頁 > 市場調查報告書 > 製藥

呼吸器

市場調查報告書

商品編碼

1578236

全球氣喘治療市場研究報告 - 2024 年至 2032 年產業分析、規模、佔有率、成長、趨勢和預測

Global Asthma Therapeutics Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2024 to 2032

出版日期: 2024年09月01日 | 出版商:

Value Market Research | 英文 132 Pages | 商品交期: 最快1-2個工作天內

價格

簡介目錄圖表

全球氣喘治療市場需求預計將從 2023 年的 320.8 億美元達到 2032 年近 534.7 億美元的市場規模，2024-2032 年研究期間複合年成長率為 5.84%。

氣喘通常是由室內和室外因素引起的，例如污染、過敏原和灰塵。氣喘治療是指一類用於治療氣喘的藥物。這些藥物通常是支氣管擴張劑和抗發炎劑。這些藥物可以拓寬進入肺部的通道，促進空氣流通，進而改善呼吸。它們還有助於清除肺部的黏液，這些黏液很容易咳出。

市場動態

氣喘治療市場可能在未來幾年逐漸擴大。呼吸系統疾病發生率的上升可能會推動全球氣喘治療市場的成長。氣喘是一種進行性呼吸系統疾病，可能致命。因此，呼吸系統疾病患者數量的不斷增加支持了全球氣喘治療市場的擴張。此外，吸菸者人數的增加、可支配收入的增加、對氣喘早期診斷優勢的了解的增加以及對改善醫療設施的需求的增加可能會推動氣喘治療市場的發展。由於技術先進的產品和對這些條件的認知水平不斷提高，預計該市場將會發展。氣喘治療生物製劑領域不斷湧現的研究被視為市場最有前景的前景。對抑制免疫球蛋白 E 和特定細胞激素的單株抗體也有很高的需求。另一個促進生長的因素是開發這些治療呼吸系統疾病的聯合療法。然而，藥品專利到期數量不斷增加、學名藥使用量增加以及氣喘治療成本高昂是限制全球氣喘治療市場成長的主要因素。

研究報告涵蓋波特五力模型、市場吸引力分析和價值鏈分析。這些工具有助於清晰地了解行業結構並評估全球範圍內的競爭吸引力。此外，這些工具也對全球氣喘治療市場的每個細分市場進行了包容性評估。氣喘治療產業的成長和趨勢為本研究提供了整體方法。

市場區隔

氣喘治療市場報告的這一部分提供了國家和區域層面細分市場的詳細資料，從而幫助策略師確定相應產品或服務的目標人群以及即將到來的機會。

按藥物類別

消炎劑
支氣管擴張劑
聯合療法

按產品分類

吸入器（乾粉、定量、軟霧）
霧化器

依給藥途徑

口服
吸入
其他

區域分析

本節涵蓋區域前景，重點介紹北美、歐洲、亞太地區、拉丁美洲以及中東和非洲氣喘治療市場當前和未來的需求。此外，該報告重點關注所有主要地區各個應用領域的需求、估計和預測。

該研究報告還涵蓋了市場主要參與者的全面概況以及對全球競爭格局的深入了解。氣喘治療市場的主要參與者包括Teva Pharmaceutical Industries Ltd.、GSK Plc、Merck & Co. Inc.、F. Hoffmann-La Roche Ltd、阿斯特捷利康、勃林格殷格翰國際有限公司、賽諾菲、Koninklijke Philips NV、BD、Covis製藥。本節包含競爭格局的整體視圖，包括各種策略發展，例如關鍵併購、未來產能、合作夥伴關係、財務概況、合作、新產品開發、新產品發布和其他發展。

如果您有任何客製化要求，請寫信給我們。我們的研究團隊可以根據您的需求提供客製化報告。

區域展望
介紹
北美銷售分析
- 概覽、歷史與預測資料銷售分析
- 北美按細分市場銷售分析
- 北美按國家銷售分析
- 美國銷售分析
- 加拿大銷售分析
- 墨西哥銷售分析
歐洲銷售分析
- 概覽、歷史與預測資料銷售分析
- 歐洲按細分市場銷售分析
- 歐洲按國家銷售分析
- 英國銷售分析
- 法國銷售分析
- 德國銷售分析
- 義大利銷售分析
- 俄羅斯銷售分析
- 歐洲其他地區銷售分析
亞太地區銷售分析
- 概覽、歷史與預測資料銷售分析
- 亞太地區按細分市場銷售分析
- 亞太地區按國家銷售分析
- 中國銷售分析
- 印度銷售分析
- 日本銷售分析
- 韓國銷售分析
- 澳洲銷售分析
- 東南亞銷售分析
- 亞太地區其他地區銷售分析
拉丁美洲銷售分析
- 概覽、歷史與預測資料銷售分析
- 拉丁美洲按細分市場銷售分析
- 拉丁美洲按國家銷售分析
- 巴西銷售分析
- 阿根廷銷售分析
- 秘魯銷售分析
- 智利銷售分析
- 拉丁美洲其他地區銷售分析
中東和非洲銷售分析
- 概覽、歷史與預測資料銷售分析
- 中東和非洲按細分市場銷售分析
- 中東和非洲按國家銷售分析
- 沙烏地阿拉伯銷售分析
- 阿拉伯聯合大公國銷售分析
- 以色列銷售分析
- 南非銷售分析
- 中東其他地區和非洲銷售分析

第 9 章：氣喘治療公司的競爭格局

氣喘治療市場競爭
夥伴關係/協作/協議
併購
新產品發布
其他發展

第 10 章：公司簡介

頂級公司市佔率分析
市場集中度
Teva Pharmaceutical Industries Ltd.

公司概況
公司收入
產品
最新動態

GSK Plc

公司概況
公司收入
產品
最新動態

Merck & Co. Inc.

公司概況
公司收入
產品
最新動態

F. Hoffmann-La Roche Ltd

公司概況
公司收入
產品
最新動態

AstraZeneca

公司概況
公司收入
產品
最新動態

Boehringer Ingelheim International GmbH

公司概況
公司收入
產品
最新動態

Sanofi.

公司概況
公司收入
產品
最新動態

Koninklijke Philips NV

公司概況
公司收入
產品
最新動態

公司概況
公司收入
產品
最新動態

Covis Pharma

公司概況
公司收入
產品
最新動態

註 - 在公司概況中，財務詳細資訊和最新發展視情況而定，或對私人公司而言可能不包括在內

簡介目錄圖表

Product Code: VMR11217451

The global demand for Asthma Therapeutics Market is presumed to reach the market size of nearly USD 53.47 Billion by 2032 from USD 32.08 Billion in 2023 with a CAGR of 5.84% under the study period 2024-2032.

Asthma is typically caused by indoor and outdoor factors such as pollution, allergens, and dust. Asthma therapeutics refers to a class of pharmacological medications used to treat asthma. These medications are often bronchodilators and anti-inflammatory agents. These medications widen the pathway into the lungs and allow for the flow of air, which improves breathing. They also help remove mucus from the lungs, which is easily coughed out.

MARKET DYNAMICS

The asthma therapeutics market is likely to expand gradually in the coming years. The rising incidence of respiratory disorders is likely to fuel worldwide asthma treatments market growth. Asthma is a progressive respiratory condition that can be fatal. As a result, the growing number of respiratory illness patients supports the expansion of the worldwide asthma therapeutics market. Also, an expanding population of smokers, an increase in disposable income, increased knowledge about the advantages of earlier diagnosis of asthma, and increased demand for improved healthcare facilities are likely to boost the asthma treatment market. The market is expected to develop due to technologically sophisticated goods and growing awareness levels regarding these conditions. Rising research in the realm of biologics for asthma therapy is viewed as the market's most promising prospect. There is also a high need for monoclonal antibodies that inhibit immunoglobulin E and particular cytokines. Another growth-promoting factor is the development of these combination treatments to treat respiratory disorders. However, the rising number of medication patent expirations, the increased usage of generic pharmaceuticals, and the high cost of asthma treatment are primary factors constraining the worldwide asthma therapeutics market's growth.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of Asthma Therapeutics. The growth and trends of Asthma Therapeutics industry provide a holistic approach to this study.

MARKET SEGMENTATION

This section of the Asthma Therapeutics market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Drug Class

Anti- Inflammatory
Bronchodilators
Combination Therapy

By Product

Inhalers (Dry Powder, Metered Dose, Soft Mist)
Nebulizers

By Route of Administration

Oral
Inhaled
Others

REGIONAL ANALYSIS

This section covers the regional outlook, which accentuates current and future demand for the Asthma Therapeutics market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Asthma Therapeutics market include Teva Pharmaceutical Industries Ltd., GSK Plc, Merck & Co. Inc., F. Hoffmann-La Roche Ltd, AstraZeneca, Boehringer Ingelheim International GmbH, Sanofi., Koninklijke Philips N.V., BD, Covis Pharma. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

1. PREFACE

1.1. Report Description
- 1.1.1 Objective
- 1.1.2 Target Audience
- 1.1.3 Unique Selling Proposition (USP) & offerings
1.2. Research Scope
1.3. Research Methodology
- 1.3.1 Market Research Process
- 1.3.2 Market Research Methodology

2. EXECUTIVE SUMMARY

2.1. Highlights of Market
2.2. Global Market Snapshot

3. ASTHMA THERAPEUTICS - INDUSTRY ANALYSIS

3.1. Introduction - Market Dynamics
3.2. Market Drivers
3.3. Market Restraints
3.4. Opportunities
3.5. Industry Trends
3.6. Porter's Five Force Analysis
3.7. Market Attractiveness Analysis
- 3.7.1 Market Attractiveness Analysis By Drug Class
- 3.7.2 Market Attractiveness Analysis By Product
- 3.7.3 Market Attractiveness Analysis By Route of Administration
- 3.7.4 Market Attractiveness Analysis By Region

4. VALUE CHAIN ANALYSIS

4.1. Value Chain Analysis
4.2. Raw Material Analysis
- 4.2.1 List of Raw Materials
- 4.2.2 Raw Material Manufactures List
- 4.2.3 Price Trend of Key Raw Materials
4.3. List of Potential Buyers
4.4. Marketing Channel
- 4.4.1 Direct Marketing
- 4.4.2 Indirect Marketing
- 4.4.3 Marketing Channel Development Trend

5. GLOBAL ASTHMA THERAPEUTICS MARKET ANALYSIS BY DRUG CLASS

5.1. Overview By Drug Class
5.2. Historical and Forecast Data Analysis By Drug Class
5.3. Anti- Inflammatory Historic and Forecast Sales By Regions
5.4. Bronchodilators Historic and Forecast Sales By Regions
5.5. Combination Therapy Historic and Forecast Sales By Regions

6. GLOBAL ASTHMA THERAPEUTICS MARKET ANALYSIS BY PRODUCT

6.1. Overview By Product
6.2. Historical and Forecast Data Analysis By Product
6.3. Inhalers (Dry Powder, Metered Dose, Soft Mist) Historic and Forecast Sales By Regions
6.4. Nebulizers Historic and Forecast Sales By Regions

7. GLOBAL ASTHMA THERAPEUTICS MARKET ANALYSIS BY ROUTE OF ADMINISTRATION

7.1. Overview By Route of Administration
7.2. Historical and Forecast Data Analysis By Route of Administration
7.3. Oral Historic and Forecast Sales By Regions
7.4. Inhaled Historic and Forecast Sales By Regions
7.5. Others Historic and Forecast Sales By Regions

8. GLOBAL ASTHMA THERAPEUTICS MARKET ANALYSIS BY GEOGRAPHY

8.1. Regional Outlook
8.2. Introduction
8.3. North America Sales Analysis
- 8.3.1 Overview, Historic and Forecast Data Sales Analysis
- 8.3.2 North America By Segment Sales Analysis
- 8.3.3 North America By Country Sales Analysis
- 8.3.4 United States Sales Analysis
- 8.3.5 Canada Sales Analysis
- 8.3.6 Mexico Sales Analysis
8.4. Europe Sales Analysis
- 8.4.1 Overview, Historic and Forecast Data Sales Analysis
- 8.4.2 Europe By Segment Sales Analysis
- 8.4.3 Europe By Country Sales Analysis
- 8.4.4 United Kingdom Sales Analysis
- 8.4.5 France Sales Analysis
- 8.4.6 Germany Sales Analysis
- 8.4.7 Italy Sales Analysis
- 8.4.8 Russia Sales Analysis
- 8.4.9 Rest Of Europe Sales Analysis
8.5. Asia Pacific Sales Analysis
- 8.5.1 Overview, Historic and Forecast Data Sales Analysis
- 8.5.2 Asia Pacific By Segment Sales Analysis
- 8.5.3 Asia Pacific By Country Sales Analysis
- 8.5.4 China Sales Analysis
- 8.5.5 India Sales Analysis
- 8.5.6 Japan Sales Analysis
- 8.5.7 South Korea Sales Analysis
- 8.5.8 Australia Sales Analysis
- 8.5.9 South East Asia Sales Analysis
- 8.5.10 Rest Of Asia Pacific Sales Analysis
8.6. Latin America Sales Analysis
- 8.6.1 Overview, Historic and Forecast Data Sales Analysis
- 8.6.2 Latin America By Segment Sales Analysis
- 8.6.3 Latin America By Country Sales Analysis
- 8.6.4 Brazil Sales Analysis
- 8.6.5 Argentina Sales Analysis
- 8.6.6 Peru Sales Analysis
- 8.6.7 Chile Sales Analysis
- 8.6.8 Rest of Latin America Sales Analysis
8.7. Middle East & Africa Sales Analysis
- 8.7.1 Overview, Historic and Forecast Data Sales Analysis
- 8.7.2 Middle East & Africa By Segment Sales Analysis
- 8.7.3 Middle East & Africa By Country Sales Analysis
- 8.7.4 Saudi Arabia Sales Analysis
- 8.7.5 UAE Sales Analysis
- 8.7.6 Israel Sales Analysis
- 8.7.7 South Africa Sales Analysis
- 8.7.8 Rest Of Middle East And Africa Sales Analysis

9. COMPETITIVE LANDSCAPE OF THE ASTHMA THERAPEUTICS COMPANIES

9.1. Asthma Therapeutics Market Competition
9.2. Partnership/Collaboration/Agreement
9.3. Merger And Acquisitions
9.4. New Product Launch
9.5. Other Developments

10. COMPANY PROFILES OF ASTHMA THERAPEUTICS INDUSTRY

10.1. Top Companies Market Share Analysis
10.2. Market Concentration Rate
10.3. Teva Pharmaceutical Industries Ltd.
- 10.3.1 Company Overview
- 10.3.2 Company Revenue
- 10.3.3 Products
- 10.3.4 Recent Developments
10.4. GSK Plc
- 10.4.1 Company Overview
- 10.4.2 Company Revenue
- 10.4.3 Products
- 10.4.4 Recent Developments
10.5. Merck & Co. Inc.
- 10.5.1 Company Overview
- 10.5.2 Company Revenue
- 10.5.3 Products
- 10.5.4 Recent Developments
10.6. F. Hoffmann-La Roche Ltd
- 10.6.1 Company Overview
- 10.6.2 Company Revenue
- 10.6.3 Products
- 10.6.4 Recent Developments
10.7. AstraZeneca
- 10.7.1 Company Overview
- 10.7.2 Company Revenue
- 10.7.3 Products
- 10.7.4 Recent Developments
10.8. Boehringer Ingelheim International GmbH
- 10.8.1 Company Overview
- 10.8.2 Company Revenue
- 10.8.3 Products
- 10.8.4 Recent Developments
10.9. Sanofi.
- 10.9.1 Company Overview
- 10.9.2 Company Revenue
- 10.9.3 Products
- 10.9.4 Recent Developments
10.10. Koninklijke Philips N.V.
- 10.10.1 Company Overview
- 10.10.2 Company Revenue
- 10.10.3 Products
- 10.10.4 Recent Developments
10.11. BD
- 10.11.1 Company Overview
- 10.11.2 Company Revenue
- 10.11.3 Products
- 10.11.4 Recent Developments
10.12. Covis Pharma
- 10.12.1 Company Overview
- 10.12.2 Company Revenue
- 10.12.3 Products
- 10.12.4 Recent Developments

Note - In company profiling, financial details and recent developments are subject to availability or might not be covered in the case of private companies

簡介目錄圖表

LIST OF TABLES

Market Snapshot
Drivers: Impact Analysis
Restraints: Impact Analysis
List of Raw Material
List of Raw Material Manufactures
Analysis By Drug Class (USD MN)
Anti- Inflammatory Market Sales By Geography (USD MN)
Bronchodilators Market Sales By Geography (USD MN)
Combination Therapy Market Sales By Geography (USD MN)
Analysis By Product (USD MN)
Inhalers (Dry Powder, Metered Dose, Soft Mist) Market Sales By Geography (USD MN)
Nebulizers Market Sales By Geography (USD MN)
Analysis By Route of Administration (USD MN)
Oral Market Sales By Geography (USD MN)
Inhaled Market Sales By Geography (USD MN)
Others Market Sales By Geography (USD MN)
Global Asthma Therapeutics Market Sales By Geography (USD MN)
North America Market Analysis (USD MN)
United States Market Analysis (USD MN)
Canada Market Analysis (USD MN)
Mexico Market Analysis (USD MN)
Europe Market Analysis (USD MN)
Europe Market Estimate By Country (USD MN)
United Kingdom Market Analysis (USD MN)
France Market Analysis (USD MN)
Germany Market Analysis (USD MN)
Italy Market Analysis (USD MN)
Russia Market Analysis (USD MN)
Spain Market Analysis (USD MN)
Rest of Europe Market Analysis (USD MN)
Asia Pacific Market Analysis (USD MN)
China Market Analysis (USD MN)
Japan Market Analysis (USD MN)
India Market Analysis (USD MN)
South Korea Market Analysis (USD MN)
Australia Market Analysis (USD MN)
South East Asia Market Analysis (USD MN)
Rest of Asia Pacific Market Analysis (USD MN)
Latin America Market Analysis (USD MN)
Brazil Market Analysis (USD MN)
Argentina Market Analysis (USD MN)
Peru Market Analysis (USD MN)
Chile Market Analysis (USD MN)
Rest of Latin America Market Analysis (USD MN)
Middle East & Africa Market Analysis (USD MN)
Saudi Arabia Market Analysis (USD MN)
UAE Market Analysis (USD MN)
Israel Market Analysis (USD MN)
South Africa Market Analysis (USD MN)
Rest of Middle East and Africa Market Analysis (USD MN)
Partnership/Collaboration/Agreement
Mergers And Acquisition

LIST OF FIGURES

Research Scope of Asthma Therapeutics Report
Market Research Process
Market Research Methodology
Global Asthma Therapeutics Market Size, By Region (USD MN)
Porters Five Forces Analysis
Market Attractiveness Analysis By Drug Class
Market Attractiveness Analysis By Product
Market Attractiveness Analysis By Route of Administration
Market Attractiveness Analysis By Region
Value Chain Analysis
Global Market Analysis By Drug Class (USD MN)
Anti- Inflammatory Market Sales By Geography (USD MN)
Bronchodilators Market Sales By Geography (USD MN)
Combination Therapy Market Sales By Geography (USD MN)
Global Market Analysis By Product (USD MN)
Inhalers (Dry Powder, Metered Dose, Soft Mist) Market Sales By Geography (USD MN)
Nebulizers Market Sales By Geography (USD MN)
Global Market Analysis By Route of Administration (USD MN)
Oral Market Sales By Geography (USD MN)
Inhaled Market Sales By Geography (USD MN)
Others Market Sales By Geography (USD MN)
Global Market Sales (USD MN)
North America Market Sales (USD MN)
Europe Market Sales (USD MN)
Asia Pacific Market Sales (USD MN)
Latin America Market Sales (USD MN)
Middle East & Africa Market Sales (USD MN)
Recent Development in Industry
Top Company Market Share Analysis